Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
about
Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and futureHyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry.5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and MortalityLaparoscopic HIPEC: A bridge between open and closed-techniques.Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis.Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.Feasibility and acceptability of PrE-operative Physical Activity to improve patient outcomes After major cancer surgery: study protocol for a pilot randomised controlled trial (PEPA Trial).
P2860
Q26768296-8C4BAD36-001F-48E4-91B0-C74EAE9303AAQ35632050-D9F68F6C-83C4-4042-AD46-86EC55341DA6Q36034107-162FBB3A-3018-4489-BD1F-B2C5245E6F13Q36915199-E7DDCD5A-D9C9-4E1C-85DA-FA3B513E3AA9Q38307144-8DE75355-2274-4782-B429-D12C97128A31Q38461953-03AAB25B-F031-47D7-B6A4-BD669DC80645Q39406537-D3FF282B-FC3F-48D2-8C66-60F31F197C84Q40242470-EBC57757-CA11-4728-8B97-8D9728586ED3Q41772742-1354D10F-4943-4D76-BAF2-5B083A5719A1Q48179612-B72E22E2-F425-4FB1-8BEB-142AD11492C4Q48348086-AEAB27BF-F718-4409-ABFD-8897AF22A94AQ48367737-ED15136C-D7B7-48AD-B958-4233AF6B7208Q49920806-00C24FEC-C821-42FB-A7CA-6DA56BE8D1D4
P2860
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
@en
type
label
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
@en
prefLabel
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
@en
P2093
P2860
P356
P1476
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
@en
P2093
Edward A Levine
John H Stewart
Konstantinos I Votanopoulos
Perry Shen
Shuja Ahmed
P2860
P304
P356
10.1002/JSO.23749
P577
2014-08-28T00:00:00Z